Stock Under $10 with 50-100% upside potential - 14 Days FREE!

Analysts' Actions: CIT, DNDN, NYT, PFE, RIMM

Stock quotes in this article: CIT, CLH, CREE, DNDN, LULU, NYT, PFE, RIMM 

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK (TheStreet) -- CHANGE IN RATINGS, EPS

CIT Group (CIT) estimates lowered at Sterne Agee CIT estimates lowered through 2011. Incorporating debt repayments. Maintain $50 price target and Buy rating.

Clean Harbors (CLH) upgraded at JP Morgan from Neutral to Overweight. $70 price target. Stock is attractive, following a 13% pullback.

Cree (CREE) downgraded at Wunderlich from Hold to Sell. $25 price target. The weakness is global chip bookings could soon accelerate.

Dendreon (DNDN) target cut at ThinkEquity to $21. Pricing in full restructuring costs. Buy rating.

Diamond Foods (DMND) target raised at KeyBanc to $85. Ongoing investments in advertising and new products. Buy rating.

Ecolab (ECL) target raised at Citigroup to $57. Solid product pipeline and good progress on EMEA restructuring. Buy rating.

The Hartford (HIG) estimates, target lowered at UBS. Shares of HIG now seen reaching $38. Estimates also cut on likely large 3Q11 deferred acquisition costs. Buy rating.

Hill-Rom (NYT) rated new Overweight at Morgan Stanley. $37 price target. Company can deliver consistent growth over the coming years.

Kroger (KR) estimates, target lowered at Jefferies. Shares of KR now seen reaching $26. Estimates also lowered on flat volumes. Buy rating.

Lululemon (LULU) estimates, target increased at Credit Suisse. LULU estimates were raised through 2014. Higher sales is driving wider margins. Neutral rating and new $59 price target.

Lululemon estimates, target increased at Jefferies. Shares of LULU now seen reaching $59. Estimates also raised on continued global strength in market demand. Hold rating.

McDonalds (MCD) estimates, target cut at UBS. Shares of MCD now seen reaching $96. Estimates also lowered following weaker than expected August SSS. Buy rating.

Mosaic (MOS) upgraded at Goldman to Buy. Company is leveraged to an improving supply/demand outlook.

Myriad Genetics (MYGN) upgraded at Auriga from Hold to Buy. $24 price target. Company can deliver solid growth in 2012.

New York Times (NYT) estimates, target lowered at UBS. Shares of NYT now seen reaching $8. Estimates also lowered on apparent slowing in September. Neutral rating.

Oracle (ORCL) added to Conviction Buy List at Goldman. Pullback has created an attractive buying opportunity. $33 price target.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,354.40 121.18 0.80%
NASDAQ 3,498.97 33.73 0.97%
S&P 500 1,667.47 17.00 1.03%
US 10 Yr 1.949% +0.084

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs